Clinuvel Pharmaceuticals
CUV.AX
#6820
Rank
โ‚ฌ0.41 B
Marketcap
8,33ย โ‚ฌ
Share price
-1.02%
Change (1 day)
-9.71%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2023: โ‚ฌ48.33 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ48.33 Million. In 2023 the company made a revenue of โ‚ฌ48.33 Million an increase over the revenue in the year 2022 that were of โ‚ฌ42.15 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2023

Annual revenue

Year Revenue Change
2023โ‚ฌ48.33 M14.65%
2022โ‚ฌ42.15 M25.45%
2021โ‚ฌ33.6 M61.08%
2020โ‚ฌ20.86 M2.65%
2019โ‚ฌ20.32 M15.55%
2018โ‚ฌ17.58 M46.83%
2017โ‚ฌ11.97 M176.95%
2016โ‚ฌ4.32 M107.69%
2015โ‚ฌ2.08 M7.83%
2014โ‚ฌ1.93 M45.96%
2013โ‚ฌ1.32 M91.73%
2012โ‚ฌ0.69 M-33.49%
2011โ‚ฌ1.03 M
2010N/A
2009N/A
2008N/A-100%
2007โ‚ฌ0.22 M-57.21%
2006โ‚ฌ0.52 M489.62%
2005โ‚ฌ0.08 M
2004N/A
2002N/A
2001N/A